Nala launches Arabic AI platform for healthcare, raises $1M in funding

Nala, a Riyadh, Saudi Arabia-based digital health company, has launched a new AI platform for medical diagnosis. According to Nala, it is the first platform to provide users with diagnoses in Arabic.

“Our mission is to reduce the cost of healthcare by a tenfold while providing exceptional healthcare experience,” Othman Abahussein, founder and CEO of Nala, said in a prepared statement. “Our whole team is in Riyadh, and all of our human capital investments go into local talent. We made a bet on local talent, and I can say with full confidence that it pays very well.”

The company, which first launched back in February, is viewed as an important part of the country’s Saudi Vision 2030 plan. Nala has also been praised by Saudi Arabia’s minister of communication and information technology.

In addition, Nala announced that it has raised $1 million in financing. Dubai-based AIAraby Investment led the funding, and the money is expected to go toward “further strengthening its position as the region’s top digital health service.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.